Dov Goldstein
Molecular and Cell Biology
Schrodinger
Australia
Biography
Dov Goldstein, brings to Schrödinger over 20 years of strategic financial experience in the healthcare sector, most recently as a Managing Partner at Aisling Capital, a leading healthcare venture capital and private equity firm with over $1.8 billion under management, where he sourced and led investments in private and public companies, including as a Board Director of 5 companies that went public. Before Aisling Capital, Dr. Goldstein served as CFO at Vicuron Pharmaceuticals and Loxo Oncology, and was Director of Venture Analysis at Healthcare Ventures. Prior to joining the financial industry, he completed his internal medicine internship at Columbia Presbyterian Hospital. Dr. Goldstein holds an M.B.A from Columbia Business School, an M.D. from Yale University School of Medicine, and a B.S. in Biological Sciences from Stanford University.
Research Interest
Molecular and Cell Biology
